Literature DB >> 15031453

Tissue plasminogen activator -7351C/T enhancer polymorphism is a risk factor for lacunar stroke.

Jim Jannes1, Monica A Hamilton-Bruce, Louis Pilotto, Brian J Smith, Charles G Mullighan, Peter G Bardy, Simon A Koblar.   

Abstract

BACKGROUND AND
PURPOSE: Occlusive thrombosis is an important component of small- and large-vessel ischemic stroke. Endogenous tissue plasminogen activator (TPA) is the primary mediator of intravascular fibrinolysis and is predominantly expressed by the endothelium of small vessels. The acute release of TPA is influenced by the TPA -7351C/T polymorphism and therefore may play an important role in the pathogenesis of lacunar stroke. In this study, we investigated the risk of lacunar and nonlacunar ischemic stroke associated with the TPA -7351C/T polymorphism.
METHODS: We conducted a case-control study of 182 cases of ischemic stroke and 301 community controls. Participants were evaluated for known cerebrovascular risk factors, and the TPA -7351C/T genotype was established by a polymerase chain reaction (PCR) method. Logistic regression was used to determine the risk of lacunar and nonlacunar ischemic stroke associated with the TPA -7351C/T polymorphism.
RESULTS: The prevalence of the TPA -7351 CC, CT, and TT genotypes were 46%, 45%, and 9% for controls and 41%, 46%, and 13% for stroke patients, respectively. After adjustment for known cerebrovascular risk factors, the TT genotype was significantly associated with ischemic stroke (OR: 1.9; 95% CI: 1.01 to 3.6). Stratification for stroke subtype showed a significant association between the TT genotype and lacunar stroke but not nonlacunar stroke (OR: 2.7; 95% CI: 1.1 to 6.7).
CONCLUSIONS: The TPA -7351C/T polymorphism is an independent risk factor for lacunar stroke. The findings suggest that impaired fibrinolysis may play a role in the pathogenesis of lacunar stroke.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15031453     DOI: 10.1161/01.STR.0000124123.76658.6c

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  10 in total

1.  A lethal phenotype associated with tissue plasminogen deficiency in humans.

Authors:  Hanan E Shamseldin; Abdulrahman Aldeeri; Zainab Babay; Abdulrahman Alsultan; Mais Hashem; Fowzan S Alkuraya
Journal:  Hum Genet       Date:  2016-07-14       Impact factor: 4.132

Review 2.  Fibrinolysis and the control of blood coagulation.

Authors:  John C Chapin; Katherine A Hajjar
Journal:  Blood Rev       Date:  2014-09-16       Impact factor: 8.250

3.  Genetic risk factors for myocardial infarction more clearly manifest for early age of first onset.

Authors:  Boris V Titov; German J Osmak; Natalia A Matveeva; Nino G Kukava; Roman M Shakhnovich; Alexander V Favorov; Mikhail Ya Ruda; Olga O Favorova
Journal:  Mol Biol Rep       Date:  2017-07-06       Impact factor: 2.316

Review 4.  Cerebral small vessel disease: genetic risk assessment for prevention and treatment.

Authors:  Ada Lam; M Anne Hamilton-Bruce; Jim Jannes; Simon A Koblar
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

5.  Small vessel cerebrovascular disease: the past, present, and future.

Authors:  Réza Behrouz; Ali R Malek; Michel T Torbey
Journal:  Stroke Res Treat       Date:  2012-01-24

6.  Regulatory polymorphisms in extracellular matrix protease genes and susceptibility to rheumatoid arthritis: a case-control study.

Authors:  Julio Rodriguez-Lopez; Eva Perez-Pampin; Juan J Gomez-Reino; Antonio Gonzalez
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

7.  The study of t-PA, u-PA and PAI-1 genes polymorphisms in patients with abdominal aortic aneurysm.

Authors:  Katarzyna Oszajca; Konrad Wroński; Grażyna Janiszewska; Małgorzata Bieńkiewicz; Jacek Bartkowiak; Janusz Szemraj
Journal:  Mol Biol Rep       Date:  2014-01-23       Impact factor: 2.316

8.  Hypertension and Cerebral Microangiopathy (Cerebral Small Vessel Disease): Genetic and Epigenetic Aspects of Their Relationship.

Authors:  L A Dobrynina; M R Zabitova; L A Kalashnikova; E V Gnedovskaya; M A Piradov
Journal:  Acta Naturae       Date:  2018 Apr-Jun       Impact factor: 1.845

9.  The -7351C/T polymorphism in the TPA gene and ischemic stroke risk: a meta-analysis.

Authors:  Xunsha Sun; Rong Lai; Jiaoxing Li; Man Luo; Yufang Wang; Wenli Sheng
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240

Review 10.  Cardioembolic stroke diagnosis using blood biomarkers.

Authors:  Victor Llombart; Teresa Garcia-Berrocoso; Alejandro Bustamante; Israel Fernandez-Cadenas; Joan Montaner
Journal:  Curr Cardiol Rev       Date:  2013-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.